Viridian Therapeutics, Inc. (VRDN)
NASDAQ: VRDN · Real-Time Price · USD
32.02
-0.44 (-1.36%)
At close: Dec 5, 2025, 4:00 PM EST
32.00
-0.02 (-0.06%)
After-hours: Dec 5, 2025, 6:05 PM EST
Viridian Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '25 Dec 5, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 3,056 | 1,519 | 1,145 | 1,176 | 429 | 64 | |
| Market Cap Growth | 89.68% | 32.58% | -2.58% | 173.76% | 568.00% | 321.43% | |
| Enterprise Value | 2,589 | 977 | 989 | 892 | 379 | 44 | |
| Last Close Price | 32.02 | 19.17 | 21.78 | 29.21 | 19.77 | 16.45 | |
| PS Ratio | 36.74 | 5028.17 | 3647.53 | 663.46 | 144.94 | 61.23 | |
| PB Ratio | 8.38 | 2.26 | 2.59 | 2.98 | 2.29 | 0.54 | |
| P/TBV Ratio | 9.73 | 3.15 | 4.86 | 4.65 | 7.97 | - | |
| EV/Sales Ratio | 36.58 | 3236.51 | 3150.76 | 503.65 | 127.79 | 41.48 | |
| Debt / Equity Ratio | 0.05 | 0.03 | 0.05 | 0.01 | 0.00 | 0.00 | |
| Asset Turnover | 0.11 | 0 | 0.00 | 0.01 | 0.02 | 0.01 | |
| Quick Ratio | 11.06 | 14.99 | 17.93 | 12.73 | 14.48 | 11.96 | |
| Current Ratio | 11.28 | 15.43 | 18.27 | 12.93 | 14.68 | 12.14 | |
| Return on Equity (ROE) | -49.89% | -48.48% | -56.80% | -44.57% | -51.61% | -163.07% | |
| Return on Assets (ROA) | -30.08% | -30.32% | -34.37% | -26.28% | -29.75% | -31.36% | |
| Return on Capital (ROIC) | -32.26% | -32.26% | -36.80% | -28.52% | -32.28% | -35.04% | |
| Return on Capital Employed (ROCE) | -61.70% | -43.10% | -54.90% | -33.40% | -41.90% | -33.60% | |
| Earnings Yield | -8.03% | -17.78% | -20.76% | -11.05% | -18.49% | -172.21% | |
| FCF Yield | -10.68% | -15.33% | -16.16% | -8.05% | -12.79% | -46.39% | |
| Buyback Yield / Dilution | -34.66% | -51.68% | -39.48% | -169.22% | -235.07% | -70.27% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.